KeyCorp Lowers HCA Healthcare (NYSE:HCA) Price Target to $370.00

HCA Healthcare (NYSE:HCA) had its target price reduced by KeyCorp from $420.00 to $370.00 in a research report report published on Tuesday morning,Benzinga reports. They currently have an overweight rating on the stock.

A number of other analysts also recently weighed in on HCA. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Barclays decreased their price target on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a report on Friday, November 8th. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their target price for the stock from $400.00 to $320.00 in a report on Monday, November 25th. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 1st. Finally, StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Stock Up 3.9 %

Shares of HCA Healthcare stock opened at $308.55 on Tuesday. HCA Healthcare has a 12 month low of $276.50 and a 12 month high of $417.14. The business has a fifty day simple moving average of $324.68 and a 200 day simple moving average of $354.48. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The stock has a market cap of $78.15 billion, a PE ratio of 13.85, a price-to-earnings-growth ratio of 1.21 and a beta of 1.64.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were issued a dividend of $0.66 per share. The ex-dividend date was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.86%. HCA Healthcare’s payout ratio is 11.85%.

Insider Activity

In other news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in HCA. FMR LLC grew its position in HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after buying an additional 2,397,883 shares in the last quarter. Darsana Capital Partners LP increased its position in shares of HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after purchasing an additional 400,000 shares during the period. Meritage Group LP acquired a new stake in HCA Healthcare during the third quarter worth about $150,548,000. Holocene Advisors LP increased its stake in HCA Healthcare by 210.6% in the third quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock valued at $124,691,000 after acquiring an additional 208,015 shares during the last quarter. Finally, Nordea Investment Management AB raised its holdings in shares of HCA Healthcare by 29.7% during the 4th quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock worth $253,020,000 after buying an additional 193,075 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.